SOTO: Treatment Sensitivity of Organoids to Predict Treatment Outcome
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Head and Neck Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
ITIL-168 in Advanced Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
HYpofractionated, Dose-redistributed RAdiotherapy With Protons and Photons in HNSCC
- Status
- RECRUITING
- Phase
- NA
A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Nimotuzumab Combined With Neoadjuvant Chemotherapy in the Treatment of Resectable LA HNSCC
- Status
- UNKNOWN
- Phase
- PHASE2
The Efficacy and Safety of Neoadjuvant Low-dose Radiotherapy Combined With Chemoimmunotherapy in Locally Advanced HNSCC
- Status
- RECRUITING
- Phase
- PHASE2
Intensive Symptom Surveillance Guided by Machine Learning-Directed Risk Stratification in Patients With Non-Metastatic Head and Neck Cancer, The INSIGHT Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Pilot Study of Glutamine PET Imaging of Head and Neck Squamous Cell Carcinoma
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
BH4 in the Prevention and Treatment of Radiation-induced Skin Reactions for Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)
- Status
- UNKNOWN
- Phase
- PHASE1
Predicting Immunotherapy Efficacy in Head and Neck Squamous Cell Cancer
- Status
- WITHDRAWN
- Phase
- N/A
Trial of Neoadjuvant Therapy With Paclitaxel and Carboplatin in Operable Locally Advanced Head and Neck Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Accelerated RTH in Squamous Cell Carcinoma in Head and Neck
- Status
- UNKNOWN
- Phase
- N/A
DAHANCA 27 Transoral Laser Microsurgery for T1a Glottic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Trial of the Combination of GX-188E Vaccination, GX-I7 and Pembrolizumab in Patients With Advanced, Resectable HPV Type 16 and/or 18 Positive Head and Neck Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
HPV 16-positive and/or HPV 18-positive Recurrent and/or For Patients With Metastatic Head and Neck Cancer to Evaluate GX-188E DNA Vaccination, GX-I7 and Nivolumab Combination Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Pembrolizumab and Induction Chemotherapy in Locally Advanced HNSCC
- Status
- RECRUITING
- Phase
- PHASE2
Develop and Test the 'Multi-Faced Continuous Exercise Program' in Operable Head and Neck Cancer Patients
- Status
- UNKNOWN
- Phase
- NA
P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1